Search Results - "VIGUIER, J"

Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy by Cézé, N., Thibault, G., Goujon, G., Viguier, J., Watier, H., Dorval, E., Lecomte, T.

“…Background Lymphopenia is a predictor of the efficacy and hematological toxicity of chemotherapy in various advanced cancers. There is little data about this…”
Get full text

Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer by Faivre, J, Dancourt, V, Denis, B, Dorval, E, Piette, C, Perrin, Ph, Bidan, J.M, Jard, C, Jung, S, Levillain, R, Viguier, J, Bretagne, J.F

“…Abstract Background The aim of this study was to compare the performance of the guaiac-based faecal occult blood test (G-FOBT), with that of three…”
Get full text

Breast cancer screening: Impact on care pathways by Lefeuvre, D., Catajar, N., Le Bihan Benjamin, C., De Bels, F., Viguier, J., Bousquet, P.-J.

Get full text

Supportive care: Patient expectations, availability and uptake by Simon, H., Viguier, J., Ganem, G.M., Touboul, C., Lhomel, C., Naman, H., Morère, J.F., Eisinger, F.

Get full text

Structure‐function relationship between a natural cosmetic active ingredient and the olfactory receptor OR2AT4 by Verzeaux, L., Richer, S., Viguier, J., Gofflo, S., Boudier, D., Aymard, E., Closs, B.

“…Objective Although the olfactory receptor OR2AT4 was described as involved in epidermal renewal, there is no data about a cosmetic active ingredient activating…”
Get full text

Indicators of non-uptake of breast cancer screening: Results from the EDIFICE 6 survey by Morere, J.-F., Viguier, J., Greillier, L., Roupret, M., Touboul, C., Lhomel, C., Couraud, S., de La Motte Rouge, T., Eisinger, F.

Get full text

Profile of individuals who never undergo colorectal cancer screening by Viguier, J., Morère, J.F., Couraud, S., Roupret, M., Touboul, C., Lhomel, C., Greillier, L., de La Motte Rouge, T., Eisinger, F.

Get full text

Indicators of non-participation in cervical cancer screening: Results from the EDIFICE 6 survey by de La Motte Rouge, T., Couraud, S., Eisinger, F., Roupret, M., Brignoli-Guibaudet, L., Lhomel, C., Greillier, L., Viguier, J., Morère, J.F.

Get full text

Social and behavioral indicators of undergoing a screening test for lung cancer by Couraud, S., Morère, J.F., Viguier, J., Roupret, M., Brignoli-Guibaudet, L., Lhomel, C., de La Motte Rouge, T., Eisinger, F., Greillier, L.

Get full text

Panel Shear of Plywood in Structural Sizes - Assessment Improvement Using Digital Image Correlation by Viguier, J., Marcon, B., Butaud, J. C., Denaud, L., Collet, R.

“…This paper introduces a new test configuration for the determination of panel shear properties in structural sizes. This original test configuration has been…”
Get full text

Heat treatment of poplar plywood: modifications in physical, mechanical and durability properties by Marcon, B, Viguier, J, Candelier, K, Thevenon, MF, Butaud, JC, Pignolet, L, Gartili, A, Denaud, L, Collet, R

“…Plywood made of poplar are limited to indoor usages since poplar exhibits a rather low natural durability. Recently, wood heat treatments have been applied to…”
Get full text

Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: A cross-sectional study by Haguenoer, K, Giraudeau, B, Gaudy-Graffin, C, de Pinieux, I, Dubois, F, Trignol-Viguier, N, Viguier, J, Marret, H, Goudeau, A

“…Abstract Objective Cervical cancer screening coverage remains insufficient in most countries. Testing self-collected samples for high-risk human papillomavirus…”
Get full text

Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability by MIQUELL, C, JACOB, S, GRANDJOUAN, S, AIME, A, VIGUIER, J, SABOURIN, J-C, SARASIN, A, DUVAL, A, PRAZ, F

“…Accumulation of frameshift mutations at genes containing coding mononucleotide repeats is thought to be the major molecular mechanism by which mismatch…”
Get full text

Prostate cancer screening: contrasting trends by Eisinger, F., Morère, J. F., Touboul, C., Pivot, X., Coscas, Y., Blay, J. Y., Lhomel, C., Viguier, J.

“…Purpose: Our previously published data showed rapidly increasing rates of prostate cancer screening in men aged 50–74, which rose from 36 % in 2005 to 48 % in…”
Get full text

1101 Less cancer screening in the vulnerable population? Results from the EDIFICE 4 survey by Morere, J.F, Viguier, J, Greillier, L, Touboul, C, Blay, J.Y, Couraud, S, Cortot, A, Lhomel, C, Pivot, X, Eisinger, F

Get full text

1100 Limiting factors to appropriate follow-up in cervical cancer screening by Viguier, J, Eisinger, F, Cortot, A, Touboul, C, Blay, J.Y, Greillier, L, Couraud, S, Lhomel, C, Morére, J.F, Pivot, X

Get full text

1208 Being cured: What it means and what it takes by Eisinger, F, Pivot, X, Viguier, J, Touboul, C, Blay, J.Y, Cortot, A, Greillier, L, Lhomel, C, Couraud, S, Morére, J.F

Get full text

Impact of case management Nurses on cancer Patients: a Systematic Review by Bregman, C, Doutriaux, A, Cognet, M, Gauthier, A, Pourcel, G, Ferrari, C, Viguier, J

Get full text

1209 Lung cancer screening: Who should pay? Results from a nationwide survey by Cortot, A, Greillier, L, Morere, J.F, Touboul, C, Pivot, X, Eisinger, F, Jean-Yves, B, Lhomel, C, Viguier, J, Couraud, S

Get full text

The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: A status report in France in 2011 by Lièvre, A, Artru, P, Guiu, M, Laurent-Puig, P, Merlin, J.L, Sabourin, J.C, Viguier, J, Bastie, A, Seronde, A, Ducreux, M

“…Abstract Background The detection of KRAS mutations is mandatory to initiate an anti-epidermal growth factor receptor (EGFR) antibody in the treatment of…”
Get full text